SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-17-016119
Filing Date
2017-04-19
Accepted
2017-04-19 07:12:37
Documents
6
Period of Report
2017-04-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm 8-K 24451
2 EXHIBIT 5.1 ex5_1.htm EX-5.1 10520
3 EXHIBIT 10.1 ex10_1.htm EX-10.1 50925
4 EXHIBIT 99.1 ex99_1.htm EX-99.1 9429
5 image0.jpg GRAPHIC 2367
6 image00002.jpg GRAPHIC 4713
  Complete submission text file 0001140361-17-016119.txt   106492
Mailing Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37568 | Film No.: 17768123
SIC: 2834 Pharmaceutical Preparations